A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology
Clinical trial NCT01667536 · COMPLETED
Trial details
- NCT number
- NCT01667536
- Sponsor
- Molecular Insight Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2013-12-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.